Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDARAVONE for Cerebral infarction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 94 adverse event reports in the FDA FAERS database where EDARAVONE was used for Cerebral infarction.

Most Reported Side Effects for EDARAVONE

Side Effect Reports % Deaths Hosp.
Death 707 18.8% 705 20
Disease progression 309 8.2% 90 28
Drug ineffective 292 7.8% 44 24
Amyotrophic lateral sclerosis 199 5.3% 173 13
Fatigue 174 4.6% 4 10
Asthenia 157 4.2% 9 19
Condition aggravated 147 3.9% 13 17
Muscular weakness 138 3.7% 4 14
Dyspnoea 136 3.6% 21 45
Gait disturbance 111 3.0% 2 7
Therapeutic response unexpected 98 2.6% 1 3
Fall 90 2.4% 9 23
Speech disorder 89 2.4% 3 2
Aphasia 88 2.3% 3 6
Diarrhoea 70 1.9% 1 9

Other Indications for EDARAVONE

Amyotrophic lateral sclerosis (2,520) Product used for unknown indication (872) Thrombotic cerebral infarction (15) Antioxidant therapy (7)

Other Drugs Used for Cerebral infarction

ALTEPLASE (1,334) CLOPIDOGREL BISULFATE (516) ASPIRIN (461) ATORVASTATIN (235) CILOSTAZOL (154) RIVAROXABAN (88) ROSUVASTATIN (86) PROBUCOL (58) EDOXABAN (54) APIXABAN (50)

Related Pages

EDARAVONE Full Profile All Cerebral infarction Drugs EDARAVONE Demographics EDARAVONE Timeline